Footpath mark monitoring device for six-minute walking test

By designing a trail marker monitoring device in a 6-minute walk test, and utilizing a movable guide rail and a non-invasive cardiac output monitor, the problems of insufficient data and line interference were solved, enabling real-time monitoring of cardiopulmonary function and convenient use of the instrument.

CN224251371UActive Publication Date: 2026-05-19ZHANGJIAKOU FIRST HOSPITAL (AFFILIATED PEOPLES HOSPITAL OF ZHANGJIAKOU UNIV)
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
ZHANGJIAKOU FIRST HOSPITAL (AFFILIATED PEOPLES HOSPITAL OF ZHANGJIAKOU UNIV)
Filing Date
2025-01-20
Publication Date
2026-05-19

AI Technical Summary

Technical Problem

The existing 6-minute walk test assessment data is limited, affecting the test results, and the external wiring of the wearable monitoring device affects the walking experience.

Method used

Design a trail marking monitoring device for a 6-minute walk test, including a test trail, a movable guide rail, and a non-invasive cardiac output monitor. The device uses wheels and the movable guide rail to achieve synchronous movement of the instrument and monitor human hemodynamic parameters in real time.

Benefits of technology

This improved the experimental results, enabled real-time and continuous monitoring of changes in cardiopulmonary function, and enhanced the convenience and practicality of the instrument.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224251371U_ABST
    Figure CN224251371U_ABST
Patent Text Reader

Abstract

The utility model relates to the field of walking tests, in particular to a footpath mark monitoring device for a six-minute walking test, which comprises a test footpath and a movable guide rail, distance marks are arranged on the surface of the test footpath, the movable guide rail is arranged on one side of the test footpath, and a mark area is arranged on the other side of the test footpath. A moving seat is arranged at the upper end of the movable guide rail, guide sliding seats are fixedly mounted on the two sides of the lower end face of the moving seat and slidably connected with the upper end of the movable guide rail, and moving wheels are arranged on the two sides of the driving box; the non-invasive cardiac output monitor is additionally arranged, so that the motion state of a patient is synchronously recorded, hemodynamic parameters of the human body are continuously monitored in real time, the change of central functions in the resting, moving and motion processes is evaluated from the angle of hemodynamics, the test effect is improved, the movable guide rail is used for guiding, the movable seat synchronously follows to move, and the test efficiency is improved. And when the patient moves, the noninvasive cardiac output monitor is driven to move synchronously, so that the use of the monitor is facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of walking tests, and more particularly to a trail marking monitoring device for a 6-minute walking test. Background Technology

[0002] Patients with chronic cardiovascular disease often experience varying degrees of decreased exercise tolerance, affecting their activity levels and quality of life. Therefore, accurately assessing a patient's cardiopulmonary function and exercise tolerance during exercise is of great significance. The six-minute walk test (6MWT) can effectively replicate a patient's daily physiological state, reflecting their exercise tolerance and cardiopulmonary function under daily physical activity. It is currently widely used to evaluate a patient's exercise tolerance, the effectiveness of medical interventions, and disease prognosis, demonstrating good practicality and effectiveness. The six-minute walk test is the most common submaximal exercise test. As an examination to assess the cardiopulmonary function of patients with underlying cardiopulmonary diseases, it measures the maximum distance a patient can walk within 6 minutes, reflecting their exercise tolerance and cardiopulmonary function under daily physical activity. It is simple, economical, and safe to perform.

[0003] Currently, during the trial, it is necessary to measure and record the walking distance to facilitate the confirmation of the patient's walking distance, which will lead to the setting of a walkway structure. However, the existing 6-minute walk test assessment data is limited, which affects the test results. In addition, when adapting to wearable monitoring devices, the external wiring affects walking, which has certain limitations.

[0004] Therefore, in view of the problem that the existing 6-minute walking test has limited evaluation data, which affects the test results, a trail marking monitoring device for the 6-minute walking test can be designed. Utility Model Content

[0005] To overcome the problem that the existing 6-minute walk test has limited assessment data, which affects the test results.

[0006] The technical solution of this utility model is as follows: a trail marking monitoring device for a 6-minute walking test, including a test trail and a movable guide rail. The surface of the test trail is marked with spacing marks. The movable guide rail is set on one side of the test trail, and a marking area is set on the other side of the test trail. A movable seat is set at the upper end of the movable guide rail. Guide slides are fixedly installed on both sides of the lower end of the movable seat. The guide slides and the upper end of the movable guide rail are slidably connected. A drive box is set at the lower end of the movable seat between the two guide slides. The drive box is set with moving wheels on both sides. A drawer is installed on the surface of the movable seat. A fixed column is fixedly installed on the upper side of the movable seat. A storage box and an operating table are set on the surface of the fixed column. A non-invasive cardiac output volume monitor is set on the top of the fixed column.

[0007] Preferably, a non-invasive cardiac output monitor is added simultaneously during the walking test. During the patient's movement, the hemodynamic parameters of the human body are monitored in real time and continuously. The changes in cardiac function during rest, activity and exercise are evaluated from a hemodynamic perspective, which improves the test results. When the person walks on the test track, the movable seat is moved synchronously by the movable wheels, so that it walks synchronously with the patient. This facilitates the installation and use of the instrument and improves its convenience.

[0008] As a preferred option, the width of the test trail is 1 meter, the length of the test trail is 30 meters, the spacing of the spacing markers is 0.5 meters, and two sets of spacing markers are set on both sides of the test trail, with the text of the two sets of spacing markers facing opposite directions.

[0009] As a preferred option, the signage areas are arranged in five equally spaced sections, each with a length and width of 1 meter.

[0010] As a preferred option, the movable guide rail and the guide slide are one-to-one, and the length of the movable guide rail is adapted to the test track.

[0011] Preferably, a motor is installed in the drive box, and a transmission shaft is installed between the moving wheel and the drive box, with the transmission shaft connected to the output end of the motor.

[0012] Preferably, the storage box is located below the worktable, and both the storage box and the worktable are equipped with connecting seats at their rear ends. The connecting seats and the fixed columns are slidably connected, and the rear end face of the connecting seats is provided with locking bolts.

[0013] Preferably, the non-invasive cardiac output monitor has a display screen on its surface, and the non-invasive cardiac output monitor and the upper end of the fixed column are detachably connected.

[0014] The beneficial effects of this utility model are:

[0015] The 6-minute walk test's path marker monitoring device is equipped with a non-invasive cardiac output monitor, enabling simultaneous recording of the patient's movement status and real-time continuous monitoring of hemodynamic parameters. This allows for the assessment of changes in cardiac function during rest, activity, and exercise from a hemodynamic perspective, improving the test's effectiveness. Furthermore, the device utilizes a movable guide rail for guidance, allowing the mobile seat to move synchronously with the patient. As the patient moves, the non-invasive cardiac output monitor moves in sync, facilitating the use of the instrument. Attached Figure Description

[0016] Figure 1 The diagram shown is a schematic representation of the overall structure of the trail marking monitoring device for the 6-minute walking test of this utility model.

[0017] Figure 2 The diagram shown is a schematic representation of the movable guide rail structure of the trail marker monitoring device for the 6-minute walking test of this utility model.

[0018] Figure 3 The diagram shown is a schematic representation of the movable base of the trail marker monitoring device for the 6-minute walking test of this utility model.

[0019] Figure 4 The diagram shown is a schematic of the fixed column structure of the trail marking monitoring device for the 6-minute walking test of this utility model.

[0020] Explanation of reference numerals in the attached diagram: 1. Test walkway; 2. Movable guide rail; 3. Identification area; 4. Movable seat; 5. Guide slide; 6. Drive box; 7. Movable wheels; 8. Fixed column; 9. Storage box; 10. Operating table; 11. Non-invasive cardiac output monitor. Detailed Implementation

[0021] The present invention will be further described below with reference to the accompanying drawings and embodiments.

[0022] Please see Figures 1-4 This utility model provides an embodiment of a trail marking monitoring device for a 6-minute walking test, including a test trail 1 and a movable guide rail 2. The surface of the test trail 1 is marked with spacing markers. The test trail 1 is 1 meter wide and 30 meters long. The spacing markers are spaced 0.5 meters apart. Two sets of spacing markers are located on both sides of the test trail 1, with the text of the two sets of markers facing opposite directions. The movable guide rail 2 is located on one side of the test trail 1, and a marking area 3 is located on the other side. A movable seat 4 is located at the upper end of the movable guide rail 2. Guide slides 5 are fixedly installed on both sides of the lower end face of the movable seat 4. The guide slides 5 are slidably connected to the upper end of the movable guide rail 2, and the lower end of the movable seat 4 is located on both guide slides 5. A drive box 6 is provided between the sliding seats 5. Both sides of the drive box 6 are equipped with casters 7. A drawer is installed on the surface of the movable seat 4. A fixed column 8 is fixedly installed on the upper side of the movable seat 4. A storage box 9 and an operating table 10 are provided on the surface of the fixed column 8. A non-invasive cardiac output monitor 11 is installed on the top of the fixed column 8. The addition of the non-invasive cardiac output monitor 11 allows for real-time continuous monitoring of hemodynamic parameters during patient movement, assessing changes in cardiac function during rest, activity, and exercise from a hemodynamic perspective, thus improving experimental results. Furthermore, the casters 7 facilitate the synchronous movement of the movable seat 4 as the personnel walk on the experimental walkway 1, allowing it to follow the patient's movements, simplifying instrument installation and use, and improving convenience.

[0023] Please see Figure 1 In this embodiment, five marking areas 3 are evenly spaced, and each marking area 3 is 1 meter in length and width. Multiple marking areas 3 can be used to place rest seats or equipment and instruments for convenient use in experiments.

[0024] Please see Figure 2 and Figure 3In this embodiment, the movable guide rail 2 and the guide slide 5 correspond one-to-one. The length of the movable guide rail 2 is adapted to the test walkway 1. A motor is provided in the drive box 6. A transmission shaft is provided between the movable wheel 7 and the drive box 6. The transmission shaft is connected to the output end of the motor. By moving the movable wheel 7, the movable seat 4 moves on the movable guide rail 2 and moves along the movable guide rail 2, which is synchronized with the patient's walking movement and facilitates the use of the monitoring instrument.

[0025] Please see Figure 1 , Figure 3 and Figure 4 In this embodiment, the storage box 9 is located below the operating table 10. Both the storage box 9 and the operating table 10 are equipped with connecting seats at their rear ends. The connecting seats and the fixed column 8 are slidably connected. The rear end face of the connecting seats is provided with locking bolts. The surface of the non-invasive cardiac output monitor 11 is provided with a display screen. The upper end of the non-invasive cardiac output monitor 11 and the fixed column 8 are detachably connected. The storage box 9 facilitates the storage and placement of the instrument monitoring head, and emergency medicines and instruments can be placed through the drawer to achieve safety and ease of use.

[0026] During operation, a non-invasive cardiac output monitor 11 is added to continuously monitor human hemodynamic parameters in real time during patient movement. This allows for the assessment of changes in cardiac function during rest, activity, and exercise from a hemodynamic perspective, improving the experimental results. The experimental walkway 1 is 30 meters long, allowing personnel to walk back and forth. The distance markings on both sides facilitate the confirmation of the patient's movement distance. Multiple marked areas 3 can be used to place rest seats or equipment for convenient experimental use. The monitoring head of the non-invasive cardiac output monitor 11 needs to be installed on the patient's body. The movement of the moving wheels 7 allows the moving seat 4 to move on the movable guide rail 2 and move along the movable guide rail 2, synchronously adapting to the patient's walking movement. This facilitates wired or wireless connection and improves practicality.

[0027] Through the above steps, a non-invasive cardiac output monitor 11 is added simultaneously to continuously monitor human hemodynamic parameters in real time during patient movement. This allows for the assessment of changes in cardiac function during rest, activity, and exercise from a hemodynamic perspective, improving the test results. Furthermore, when personnel walk on the test path 1, the movable wheels 7 facilitate the synchronous movement of the movable seat 4, allowing it to walk synchronously with the patient. This simplifies the installation and use of the instrument, improving its convenience and addressing the problem of insufficient evaluation data in the existing 6-minute walk test, which affects the test results.

Claims

A trail marking monitoring device for a 1.6-minute walking test, comprising a test trail (1), characterized in that: It also includes a movable guide rail (2), the surface of the test track (1) is marked with spacing marks, the movable guide rail (2) is set on one side of the test track (1), the marking area (3) is set on the other side of the test track (1), the movable guide rail (2) is set with a movable seat (4) at the upper end, the guide slides (5) are fixedly installed on both sides of the lower end of the movable seat (4), the guide slides (5) and the upper end of the movable guide rail (2) are slidably connected, the lower end of the movable seat (4) is set with a drive box (6) between the two guide slides (5), the drive box (6) is set with movable wheels (7) on both sides, the surface of the movable seat (4) is set with a drawer, the upper side of the movable seat (4) is fixedly set with a fixed column (8), the surface of the fixed column (8) is set with a storage box (9) and an operating table (10), and the top of the fixed column (8) is set with a non-invasive cardiac output monitor (11).

2. The trail marking monitoring device for the 6-minute walking test according to claim 1, characterized in that: The width of the test trail (1) is 1 meter, the length of the test trail (1) is 30 meters, the spacing of the spacing markers is 0.5 meters, and there are two sets of spacing markers on both sides of the test trail (1), with the text of the two sets of spacing markers facing opposite directions.

3. The trail marking monitoring device for the 6-minute walking test according to claim 1, characterized in that: The five signage areas (3) are evenly spaced, and each signage area (3) is 1 meter long and 1 meter wide.

4. The trail marking monitoring device for the 6-minute walking test according to claim 1, characterized in that: The movable guide rail (2) and the guide slide (5) correspond one-to-one, and the length of the movable guide rail (2) is adapted to the test track (1).

5. The trail marking monitoring device for the 6-minute walking test according to claim 1, characterized in that: A motor is installed in the drive box (6), and a transmission shaft is installed between the moving wheel (7) and the drive box (6), and the transmission shaft is connected to the output end of the motor.

6. The trail marking monitoring device for the 6-minute walking test according to claim 1, characterized in that: The storage box (9) is located below the operating table (10). Both the storage box (9) and the operating table (10) are equipped with connecting seats at their rear ends. The connecting seats and the fixed column (8) are slidably connected. The rear end face of the connecting seats is provided with locking bolts.

7. The trail marking monitoring device for the 6-minute walking test according to claim 1, characterized in that: The surface of the non-invasive cardiac output monitor (11) is equipped with a display screen, and the upper end of the non-invasive cardiac output monitor (11) and the fixed column (8) are detachably connected.